Cerus (CERS) Net Cash Flow Growth (5y) (2015 - 2026)
Cerus (CERS) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.69% |
| Mar 31, 2026 | -17.88% |
| Dec 31, 2025 | -11.51% |
| Sep 30, 2025 | 47.22% |
| Jun 30, 2025 | -39.33% |
| Mar 31, 2025 | 5.89% |
| Dec 31, 2024 | -16.56% |
| Sep 30, 2024 | 59.12% |
| Jun 30, 2024 | -8.05% |
| Mar 31, 2024 | 129.77% |
| Dec 31, 2023 | -23.61% |
| Sep 30, 2023 | -19.08% |
| Jun 30, 2023 | -59.87% |
| Mar 31, 2023 | -32.93% |
| Dec 31, 2022 | 30.86% |
| Sep 30, 2022 | 1.54% |
| Jun 30, 2022 | -21.08% |
| Mar 31, 2022 | 2.11% |
| Dec 31, 2021 | -38.89% |
| Sep 30, 2021 | 30.67% |